217 related articles for article (PubMed ID: 15280532)
61. HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor.
De Francesco MA; Caruso A; Fallacara F; Canaris AD; Dima F; Poiesi C; Licenziati S; Corulli M; Martinelli F; Fiorentini S; Turano A
AIDS; 1998 Feb; 12(3):245-52. PubMed ID: 9517986
[TBL] [Abstract][Full Text] [Related]
62. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
Tewari D; Goldstein SL; Notkins AL; Zhou P
J Immunol; 1998 Sep; 161(5):2642-7. PubMed ID: 9725267
[TBL] [Abstract][Full Text] [Related]
63. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.
González SA; Affranchino JL
Virology; 1998 Jan; 240(1):27-35. PubMed ID: 9448686
[TBL] [Abstract][Full Text] [Related]
64. Effect of Glu12-His89 Interaction on Dynamic Structures in HIV-1 p17 Matrix Protein Elucidated by NMR.
Konagaya Y; Miyakawa R; Sato M; Matsugami A; Watanabe S; Hayashi F; Kigawa T; Nishimura C
PLoS One; 2016; 11(12):e0167176. PubMed ID: 27907055
[TBL] [Abstract][Full Text] [Related]
65. The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.
Murphy RE; Saad JS
Viruses; 2020 May; 12(5):. PubMed ID: 32429351
[TBL] [Abstract][Full Text] [Related]
66. A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17.
Morikawa Y; Kishi T; Zhang WH; Nermut MV; Hockley DJ; Jones IM
J Virol; 1995 Jul; 69(7):4519-23. PubMed ID: 7769715
[TBL] [Abstract][Full Text] [Related]
67. Conservative hydrophobic interdomain contacts of IFN-gamma remain in P17 matrix protein of HIV-1.
Denesyuk AI; Matthews S; Zav'yalov VP; Korpela T
APMIS; 1996 Feb; 104(2):141-6. PubMed ID: 8619916
[TBL] [Abstract][Full Text] [Related]
68. HIV-1 matrix protein: a mysterious regulator of the viral life cycle.
Bukrinskaya A
Virus Res; 2007 Mar; 124(1-2):1-11. PubMed ID: 17210199
[TBL] [Abstract][Full Text] [Related]
69. Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging.
Morellet N; Druillennec S; Lenoir C; Bouaziz S; Roques BP
Protein Sci; 2005 Feb; 14(2):375-86. PubMed ID: 15659370
[TBL] [Abstract][Full Text] [Related]
70. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
Saad JS; Miller J; Tai J; Kim A; Ghanam RH; Summers MF
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11364-9. PubMed ID: 16840558
[TBL] [Abstract][Full Text] [Related]
71. NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions.
Schüler W; Wecker K; de Rocquigny H; Baudat Y; Sire J; Roques BP
J Mol Biol; 1999 Feb; 285(5):2105-17. PubMed ID: 9925788
[TBL] [Abstract][Full Text] [Related]
72. Binding to PI(4,5)P
Bugatti A; Caccuri F; Filippini F; Ravelli C; Caruso A
J Biol Chem; 2021 Aug; 297(2):100934. PubMed ID: 34273353
[TBL] [Abstract][Full Text] [Related]
73. Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA.
Hermida-Matsumoto L; Resh MD
J Virol; 1999 Mar; 73(3):1902-8. PubMed ID: 9971769
[TBL] [Abstract][Full Text] [Related]
74. Comparison of the NMR and X-ray structures of the HIV-1 matrix protein: evidence for conformational changes during viral assembly.
Massiah MA; Worthylake D; Christensen AM; Sundquist WI; Hill CP; Summers MF
Protein Sci; 1996 Dec; 5(12):2391-8. PubMed ID: 8976548
[TBL] [Abstract][Full Text] [Related]
75. Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists.
Bugatti A; Giagulli C; Urbinati C; Caccuri F; Chiodelli P; Oreste P; Fiorentini S; Orro A; Milanesi L; D'Ursi P; Caruso A; Rusnati M
J Biol Chem; 2013 Jan; 288(2):1150-61. PubMed ID: 23166320
[TBL] [Abstract][Full Text] [Related]
76. Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants.
He W; Mazzuca P; Yuan W; Varney K; Bugatti A; Cagnotto A; Giagulli C; Rusnati M; Marsico S; Diomede L; Salmona M; Caruso A; Lu W; Caccuri F
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):13-24. PubMed ID: 30248376
[TBL] [Abstract][Full Text] [Related]
77. Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation.
Eastep GN; Ghanam RH; Green TJ; Saad JS
J Biol Chem; 2021; 296():100321. PubMed ID: 33485964
[TBL] [Abstract][Full Text] [Related]
78. Structural and biophysical characterizations of HIV-1 matrix trimer binding to lipid nanodiscs shed light on virus assembly.
Murphy RE; Samal AB; Vlach J; Mas V; Prevelige PE; Saad JS
J Biol Chem; 2019 Dec; 294(49):18600-18612. PubMed ID: 31640987
[TBL] [Abstract][Full Text] [Related]
79. Toward preserving the structure of the antigenic peptide p17-1 from the HIV-1 p17 protein in nanostructured films.
Petri L; Ferreira M; Moraes ML
J Nanosci Nanotechnol; 2011 Aug; 11(8):6705-9. PubMed ID: 22103071
[TBL] [Abstract][Full Text] [Related]
80. Structural and Mechanistic Studies of the Rare Myristoylation Signal of the Feline Immunodeficiency Virus.
Brown JB; Summers HR; Brown LA; Marchant J; Canova PN; O'Hern CT; Abbott ST; Nyaunu C; Maxwell S; Johnson T; Moser MB; Ablan SD; Carter H; Freed EO; Summers MF
J Mol Biol; 2020 Jun; 432(14):4076-4091. PubMed ID: 32442659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
